Wyeth Premarin Market-Share Rebates Challenged In Duramed Antitrust Suit

Wyeth-Ayerst's Premarin market share-based rebates represent an antitrust violation, Duramed maintained in a lawsuit filed Sept. 5 in Cincinnati federal court.

More from Archive

More from Pink Sheet